EKB Journal Management System

51.

Effect of Supportive Nursing Intervention on Feeling of Stigmatization and Quality of Life among Older Adults with Psoriasis

Volume 7, Issue 1, January 2024, Pages 202-225
Sally Mohammed Elsayed Ibrahim; Ghada Elhgry; Moustafa T Saad

52.

LncRNA HOTAIR as a novel biomarker in Psoriasis

Volume 12, Issue 3, December 2023, Pages 53-62
Rana Raafat Mohammed Saad; Amr Zahra; Azza Elamir; Basma Mohammed; Hassan Elsayed

53.

Isolation and Diagnosis of Some Isolated Bacterial Types of Psoriasis Patients and Measurement of Some Immunological Parameters Such as Il-17 And Complements C3 and C4

Volume 15, Issue 2, December 2023, Pages 411-417
Dalida A. A. Hussin; Asmaa E. Mahmood

54.

Dental changes in psoriasis

Volume 8, Issue 11, November 2023, Pages 73-78
Adel Ibrahim; Asmaa El Refaie; Rehab Salem; Shymaa Mostafa Rezk; walid Abdellatif; Miran Mohamed

55.

Evaluation of Faecal Calprotectin Level in Psoriatic and Hidradenitis Suppurativa Patients as a Model of an Autoimmune and Auto-Inflammatory Disease Retrospectively

Volume 93, Issue 1, October 2023, Pages 6914-6918

56.

Immunohistochemical Study of Cyclin Dependant Kinase5 (CDK5) in Some Hyperproliferative Skin Disorders

Volume 8, Issue 10, October 2023, Pages 103-110
Abd El-Aziz El-Taweel; Hamza Mohamed; Fatma El-Esawy; Essam Akl; Nehal Abd El-Aziz

57.

Role of serum IL-26 in Pathogenesis of Psoriasis vulgaris

Volume 4, Issue 4, October 2023, Pages 105-116
Soha Mahmoud Abd El-salam; Shaimaa Taha Mahmoud; Naglaa Abd Elmoniem Radi; Yasser Mostafa Gohary

58.

Impact of psoriasis disease and its treatment with Etanercept on serum and saliva thiol-disulfide homeostasis

Volume 66, Issue 9, September 2023, Pages 37-46
Hathama Razooki Hasan; Rajaa Jabir Abdel Rasul

59.

Evaluation Of Neopterin Level And Disease Severity In Patients With Psoriasis Vulgaris Treated With Narrowband UVB

Volume 6, Issue 2, July 2023, Pages 81-87
Eisa Mohamed Hegazy; Hassan Mohamed Ibrahim; Fatma Elsayed Abd Elfatah; Ali Mohamed Younis

60.

Role of Maresin-1 in Inflammatory Resolution of Psoriasis (Maresin-1, Novel Therapeutic Alternative in Psoriasis Patients)

Volume 92, Issue 1, July 2023, Pages 5615-5619
Tebarek Yahya Shaalan; Ahmed SH; Mohammed SA; Elhabak DM

61.

Female Sexual Function and Distress before and after Treatment of Moderate and Severe Psoriasis

Volume 92, Issue 1, July 2023, Pages 6075-6081

62.

Lipocalin-2 as a Significant Biomarker in Psoriasis

Volume 92, Issue 1, July 2023, Pages 6553-6560

63.

Study of Toll -like Receptor 4 and Colony Stimulating Factor 2 Gene Expression for Early Recognition of Axial Spondyloarthritis Changes in Psoriatic cases.

Volume 43, Issue 3, July 2023, Pages 219-229
Manal Abd El Monem Ellaithy; sherin sobhy elnaidany; Wafaa A Shehata; Dalia S Saif; Sally M El-Hefnawy

64.

Growth Differentiation Factor-15 in psoriatic patients: a narrative review

Volume 8, Issue 6, June 2023, Pages 99-102
Essam El-Sayed Akl; Maram Farh; nehad fouad; karem IBRAHIM

65.

Evaluation of the Effect of Narrowband Ultraviolet B Versus Methotrexate on Serum TWEAK Level in Psoriasis

Volume 3, Issue 1, June 2023, Pages 34-46
Ali Mohamed Younis; El-Hassan Rageh; Moustafa Adam El Taieb; Nour Mohammed Ahmed; Eisa Mohamed Hegazy

66.

Serum Neprilysin Is a Significant Predictor of Metabolic Syndrome in Psoriasis Patients

Volume 91, Issue 1, April 2023, Pages 3902-3906
Essam Mohamed Akl; Nehad A. Fouad; Marwa Bashir Amir Alamin; Karem Taha khalil

67.

Assessment of Serum Level of N-Terminal Pro B-Type Natriuretic Peptide as A Predictor of Cardiovascular Disease in Patients with Psoriasis Vulgaris

Volume 91, Issue 1, April 2023, Pages 4524-4530
Salma Elsayed; Elshahat Farag Ahmed Sharaf; Hamdy Foaad Ali Marzouk; Shreif Refaat Esmail

68.

Climatotherapy at Red Sea, Hurghada, versus topical combination of corticosteroids with salicylic acid in treatment of psoriasis

Volume 8, Issue 2, April 2023, Pages 62-68
Eman M. Kamal Youssef; Ahmed A. Abdel-Mageed; Abeer A. Mohamed; Mai M Elkabsh; Esraa S.E. Ahmed

69.

Priming of Psoriasis patients with supplemental folic acid could minimize the deleterious effect of PUVA on serum folic acid levels

Volume 40, Annual conference issue, March and April 2023, Pages 65-73
Samah Ibrahim; Asmaa adel elfallah; Karem Taha khalil

70.

Urotensin II in Psoriasis in relation to disease severity .

Volume 40, Annual conference issue, March and April 2023, Pages 273-282
Adel Ali Ali Ibrahim; Hamasat Abdel Hafeez Abdel Khalik; Laila Wafaa Taha; Shymaa Mostafa rezk

71.

Quality of Life among Psoriasis Patients; Correlation with Severity and Response to Psoralen Ultraviolet-A phototherapy

Volume 26, Issue 2, February 2023, Pages 10-16
Hesham Nada; Sherin Fikry; Wafaa Hagag

72.

Tissue Expression of Nuclear Factor Kappa Beta in Psoriasis Vulgaris Before and After Psoralen Ultraviolet-A Therapy: A Prospective Study

Volume 26, Issue 1, January 2023, Pages 61-69
Hesham Nada; Sherine El-Saman; Abeer Mohamed

73.

Serum Level of Survivin in Patients with Psoriasis Vulgaris and Its Relation to Disease Severity

Volume 90, Issue 2, January 2023, Pages 2363-2369
Hind Ibrahim AbdElwahab Hassan; Ahmed Fathy State; Sherief R. Esmail; Ahmad S. Hasan

74.

Peripheral Blood mRNA and Protein Levels of CCN1 and CCN3 in Psoriatic Arthritis: A Case-Control Study

Volume 90, Issue 2, January 2023, Pages 2970-2978
Marwa M. Esawy; Lobna I Kotb; Shereen A. Baioumy; Alshimaa M. Ibrahim; Marwa Shabana

75.

Role of Interleukin-18, Tumor Necrosis Factor-α, Osteopontin, Paraoxonase and Lipoprotein (a) in Psoriasis Pathogenicity.

Volume 66, Issue 1, January 2023, Pages 531-543
Amina Hamed Alobaidi; Abdulghani Mohamed Alsamarai

First Page Previous Page 1 2 3 4 5 6 7 Next Page Last Page